buspirone has been researched along with Premenstrual Syndrome in 10 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
Premenstrual Syndrome: A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lifetime psychiatric illness is also common in women with PMDD, and although mood disorders predominate, past histories of anxiety disorders are also common, further suggesting an association between PMDD and anxiety disorders." | 2.40 | Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders? ( Yonkers, KA, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nazari, H | 1 |
| Yari, F | 1 |
| Jariani, M | 1 |
| Marzban, A | 1 |
| Birgandy, M | 1 |
| Yatham, LN | 1 |
| Yonkers, KA | 1 |
| Landén, M | 1 |
| Eriksson, O | 1 |
| Sundblad, C | 1 |
| Andersch, B | 1 |
| Naessén, T | 1 |
| Eriksson, E | 1 |
| Hendler, N | 1 |
| Backerman, IA | 1 |
| Rickels, K | 2 |
| Freeman, E | 1 |
| Sondheimer, S | 1 |
| Yatham, LM | 1 |
| Barry, S | 1 |
| Dinan, TG | 1 |
| Anderson, IM | 1 |
2 reviews available for buspirone and Premenstrual Syndrome
| Article | Year |
|---|---|
Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders?
Topics: 1-Naphthylamine; Adult; Age of Onset; Anxiety; Anxiety Disorders; Buspirone; Carbon Dioxide; Comorbi | 1997 |
Buspirone in clinical practice.
Topics: Anxiety Disorders; Buspirone; Depressive Disorder; Female; Humans; Premenstrual Syndrome | 1990 |
3 trials available for buspirone and Premenstrual Syndrome
| Article | Year |
|---|---|
Premenstrual syndrome: a single-blind study of treatment with buspirone versus fluoxetine.
Topics: Adolescent; Adult; Buspirone; Female; Fluoxetine; Humans; Middle Aged; Premenstrual Syndrome; Select | 2013 |
Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo.
Topics: Adult; Buspirone; Double-Blind Method; Female; Humans; Piperazines; Premenstrual Syndrome; Psychiatr | 2001 |
Buspirone in treatment of premenstrual syndrome.
Topics: Adult; Buspirone; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Pilot Projects; Pre | 1989 |
5 other studies available for buspirone and Premenstrual Syndrome
| Article | Year |
|---|---|
Is 5HT1A receptor subsensitivity a trait marker for late luteal phase dysphoric disorder? A pilot study.
Topics: Administration, Oral; Adult; Biomarkers; Buspirone; Female; Humans; Luteal Phase; Pilot Projects; Pr | 1993 |
Spironolactone for the treatment of PMS.
Topics: Buspirone; Female; Humans; Premenstrual Syndrome; Spironolactone | 1992 |
Premenstrual syndrome update: 1991.
Topics: Adult; Buspirone; Female; Humans; Middle Aged; Premenstrual Syndrome | 1991 |
Serotonin receptors, buspirone, and premenstrual syndrome.
Topics: Buspirone; Female; Humans; Menstrual Cycle; Premenstrual Syndrome; Prolactin; Receptors, Serotonin | 1989 |
Serotonin receptors, buspirone, and premenstrual syndrome.
Topics: Buspirone; Female; Humans; Luteal Phase; Premenstrual Syndrome; Receptors, Serotonin | 1989 |